Page last updated: 2024-11-07

methylprednisolone acetate and Meningitis, Cryptococcal

methylprednisolone acetate has been researched along with Meningitis, Cryptococcal in 1 studies

Methylprednisolone Acetate: Methylprednisolone derivative that is used as an anti-inflammatory agent for the treatment of ALLERGY and ALLERGIC RHINITIS; ASTHMA; and BURSITIS; and for the treatment of ADRENAL INSUFFICIENCY.
methylprednisolone acetate : An acetate ester resulting from the formal condensation of the 21-hydroxy function of 6alpha-methylprednisolone compound with acetic acid.

Meningitis, Cryptococcal: Meningeal inflammation produced by CRYPTOCOCCUS NEOFORMANS, an encapsulated yeast that tends to infect individuals with ACQUIRED IMMUNODEFICIENCY SYNDROME and other immunocompromised states. The organism enters the body through the respiratory tract, but symptomatic infections are usually limited to the lungs and nervous system. The organism may also produce parenchymal brain lesions (torulomas). Clinically, the course is subacute and may feature HEADACHE; NAUSEA; PHOTOPHOBIA; focal neurologic deficits; SEIZURES; cranial neuropathies; and HYDROCEPHALUS. (From Adams et al., Principles of Neurology, 6th ed, pp721-2)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
McCarthy, MW1
Walsh, TJ1

Reviews

1 review available for methylprednisolone acetate and Meningitis, Cryptococcal

ArticleYear
Molecular diagnosis of invasive mycoses of the central nervous system.
    Expert review of molecular diagnostics, 2017, Volume: 17, Issue:2

    Topics: Candidiasis; Disease Outbreaks; Drug Contamination; Humans; Meningitis, Cryptococcal; Meningoencepha

2017